CHELMSFORD, Mass.-- ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced that it will display its fully-integrated portfolio of resuscitation devices and data management solutions that address each link in the Chain of Survival in Booth #100 at the American Heart Association Scientific Sessions 2010 November 14-16 at McCormick Place in Chicago. ZOLL’s technology is strongly aligned with the 2010 Guidelines’ emphasis on high-quality CPR and minimizing interruptions in chest compressions.
The increased focus in the new Guidelines on methods to ensure high-quality CPR has been an ongoing commitment of ZOLL since 2002 when it was the first to introduce real-time CPR feedback in its AED Plus. Today, all ZOLL defibrillators, from ACLS to AEDs, feature Real CPR Help audio and visual feedback for the correct rate, depth, release*, and tracking of idle time.
Further supporting the 2010 Guidelines are the R Series Code-Ready family of defibrillators for hospitals, the E Series defibrillators for EMS, and the AED Pro, which all offer See-Thru CPR, a breakthrough technology that filters out CPR artifact from the ECG to reduce CPR interruptions. Use of low energy biphasic continuous waveform capnography in the R Series and the E Series also determines tube placement, tracks resuscitation progress, and provides a clear indication of ROSC.
The E Series, when paired with the RescueNet STEMI Management Solution*, becomes an advanced and versatile system that can help health care providers speed up the treatment of patients with ST elevation Myocardial Infarction, as recommended in the 2010 Guidelines. It allows EMS providers to easily acquire and transmit ECG information from the field into the cath lab to assist clinicians in meeting standards for door-to-balloon times.
The AutoPulse Non-invasive Cardiac Support Pump is classified as a Class IIb device in the new Guidelines and provides easy-to-use, load-distributing LifeBand that squeezes the entire chest, improving blood flow to the heart and brain during sudden cardiac arrest (SCA). The AutoPulse delivers high-quality, uninterrupted CPR chest compressions to maintain myocardial and cerebral perfusion even when moving patients, traveling in an ambulance or while undergoing PCI.
Additional products that support implementation of the recommendations include:
• For early intervention, the LifeVest Wearable Defibrillator is worn by patients at risk for SCA, providing protection during their changing condition and while permanent SCA risk has not been established. The LifeVest allows a patient’s physician time to assess his/her long-term arrhythmic risk and make appropriate plans.
• For assessing performance to improve care, CodeNet is the first software system that allows hospital teams to better document, manage, and review cardiac arrest event and resuscitation information. CodeNet brings new improvements and efficiencies in data capture, event time synchronization, and case and aggregate reporting.
• The first training app to provide CPR training and practice using the just-released 2010 American Heart Association CPR Guidelines is the new version of PocketCPR for the iPhone. The application provides clear visual and audio step-by-step coaching on CPR performance and includes the initial steps to follow in the Chain of Survival. Attendees who take the CPR test on either the AED Plus or AED Pro, or listen to a product demo, will be able to download the PocketCPR application onto their iPhone or iPod Touch.
• ZOLL Intravascular Temperature Management (IVTM) offers health care providers the power and control they need to rapidly, safely, and effectively manage the core body temperature of critically ill or surgical patients.
Scientific Assembly Presentations
An education grant from ZOLL helps to underwrite the AHA Resuscitation Science Symposium (ReSS), an international forum for scientists and care providers to discuss recent advances related to treating cardiopulmonary arrest and life-threatening traumatic injury.
Twenty-one scientific presentations related to ZOLL products and technology, including eight that were recognized as “Best Presentations,” are scheduled. These studies cover ZOLL technology including Real CPR Help, See-Thru CPR, the AutoPulse, the LifeVest, and therapeutic temperature management products. Many of these research projects were completed using the information provided by data products from ZOLL, including Code Review and RescueNet, which record clinical and operational information from all ZOLL devices and products.
A listing and schedule of the presentations is available at www.zoll.com/aha-presentations; all presentations will be available from the AHA and ZOLL at the conclusion of the AHA Scientific Sessions program.
About ZOLL Medical Corporation
ZOLL Medical Corporation develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.
A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe. For more information, visit www.zoll.com.
Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AutoPulse, AED Plus, AED Pro, CodeNet, Code-Ready, E Series, IVTM, LifeBand, LifeVest, PocketCPR, R Series, Real CPR Help, RescueNet, See-Thru CPR, and Thermogard XP are trademarks and/or registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.
*Requires FDA 510 (k) and Health Canada Medical Device License clearance and is not yet available for sale in the U.S. or Canada.